HOOK
Price:
$3.82
Market Cap:
$128.54M
HOOKIPA Pharma Inc., a clinical stage biopharmaceutical company, develops immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform. The company's lead infectious disease product candidate is HB-101, which is in a randomized double-blinded Phase II clinical trial in patients awaiting kidney transplantation from cytomegalovirus-positive donors. Its lead oncology product candidates are HB-201 and HB-202 that are in Phase I/II clinical trial for the treatment of human papillomavirus 16-positive cancers. The company's preclinical stage products include HB-300 program for prostate cancer; and HB-700 for targeting mutated KRAS in pancreatic, colorect...[Read more]
Industry
Biotechnology
IPO Date
2019-04-18
Stock Exchange
NASDAQ
Ticker
HOOK
According to HOOKIPA Pharma Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.93. This represents a change of 222.91% compared to the average of -0.29 of the last 4 quarters.
The mean historical PE Ratio of HOOKIPA Pharma Inc. over the last ten years is -54.35. The current -0.93 PE Ratio has changed 71.11% with respect to the historical average. Over the past ten years (40 quarters), HOOK's PE Ratio was at its highest in in the March 2024 quarter at 1.58. The PE Ratio was at its lowest in in the December 2018 quarter at -301.98.
Average
-54.35
Median
-6.56
Minimum
-179.62
Maximum
-0.82
Discovering the peaks and valleys of HOOKIPA Pharma Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 14.71%
Maximum Annual PE Ratio = -0.82
Minimum Annual Increase = -87.07%
Minimum Annual PE Ratio = -179.62
Year | PE Ratio | Change |
---|---|---|
2023 | -0.94 | 14.71% |
2022 | -0.82 | -19.24% |
2021 | -1.01 | -84.56% |
2020 | -6.56 | -87.07% |
2019 | -50.75 | -63.94% |
2018 | -140.75 | -21.64% |
The current PE Ratio of HOOKIPA Pharma Inc. (HOOK) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-0.92
5-year avg
-12.02
10-year avg
-54.35
HOOKIPA Pharma Inc.’s PE Ratio is greater than Mereo BioPharma Group plc (-17.42), greater than Terns Pharmaceuticals, Inc. (-6.12), greater than PDS Biotechnology Corporation (-3.07), greater than Inozyme Pharma, Inc. (-3.57), greater than Day One Biopharmaceuticals, Inc. (-7.31), greater than Eledon Pharmaceuticals, Inc. (-1.48), less than X4 Pharmaceuticals, Inc. (6.04), greater than Acumen Pharmaceuticals, Inc. (-2.12), greater than Amylyx Pharmaceuticals, Inc. (-1.39),
Company | PE Ratio | Market cap |
---|---|---|
-17.42 | $636.58M | |
-6.12 | $665.36M | |
-3.07 | $125.19M | |
-3.57 | $320.57M | |
-7.31 | $1.23B | |
-1.48 | $104.69M | |
6.04 | $89.47M | |
-2.12 | $137.58M | |
-1.39 | $230.80M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like HOOKIPA Pharma Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like HOOKIPA Pharma Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is HOOKIPA Pharma Inc.'s PE Ratio?
How is the PE Ratio calculated for HOOKIPA Pharma Inc. (HOOK)?
What is the highest PE Ratio for HOOKIPA Pharma Inc. (HOOK)?
What is the 3-year average PE Ratio for HOOKIPA Pharma Inc. (HOOK)?
What is the 5-year average PE Ratio for HOOKIPA Pharma Inc. (HOOK)?
How does the current PE Ratio for HOOKIPA Pharma Inc. (HOOK) compare to its historical average?